Back to results
US 7,364,893 B2Granted
Recombinant infectious laryngotracheitis virus and uses thereof
AssigneeSchering-Plough Animal Health Corporation
InventorsMartha A. Wild, Mark D. Cochran
Life of this patent
Estimating the term…
Abstract
The present invention provides recombinant and/or isolated infectious laryngotracheitis virus glycoproteins, including gD, gI, gG and gE.
Claims20
A recombinant infectious laryngotracheitis virus comprising an infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein G (gG) gene and a deletion in the US2 gene.
Dependencies are inferred from the claim text.